Gabelli Funds LLC Sells 78,800 Shares of Option Care Health, Inc. $OPCH

Key Points

• Gabelli Funds LLC reduced its stake in Option Care Health by 14% during the first quarter, selling 78,800 shares, leaving them with 484,300 shares valued at approximately $16.93 million.
• Insider trading saw Director Timothy P. Sullivan purchasing 20,000 shares at $27.51 each, which increased his ownership by 68.43%, while Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares at $27.15 each, a 10.61% increase in ownership.
• Option Care Health's recent earnings report showed an EPS of $0.41, exceeding analysts' expectations, with revenues of $1.42 billion, marking a 15.4% increase year-over-year.

Gabelli Funds LLC decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 484,300 shares of the company's stock after selling 78,800 shares during the period. Gabelli Funds LLC owned 0.30% of Option Care Health worth $16,926,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares in the last quarter. Brooklyn Investment Group raised its stake in shares of Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after purchasing an additional 780 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after purchasing an additional 599 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. Finally, Wealthquest Corp purchased a new stake in shares of Option Care Health in the first quarter worth approximately $66,000. Institutional investors own 98.05% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on OPCH shares. JMP Securities increased their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $35.75.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan acquired 20,000 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The shares were acquired at an average cost of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director directly owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.07 during trading hours on Monday, reaching $28.68. The stock had a trading volume of 1,554,512 shares, compared to its average volume of 1,793,642. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a 50 day simple moving average of $29.60 and a 200 day simple moving average of $31.65. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The stock has a market cap of $4.65 billion, a P/E ratio of 22.94, a price-to-earnings-growth ratio of 1.75 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the business posted $0.30 earnings per share. The business's revenue for the quarter was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.